These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8619567)

  • 1. Pharmacokinetics and metabolism of 14C-isepamicin in humans following intravenous administration.
    Lin C; Korduba C; Affrime M; Radwanski E; Nomeir A; Batra V; Cutler D; Cayen MN
    Antimicrob Agents Chemother; 1995 Oct; 39(10):2201-3. PubMed ID: 8619567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of isepamicin following a single administration by intravenous infusion or intramuscular injections.
    Radwanski E; Batra V; Cayen M; Korduba C; Cutler D; Affrime M; Nomeir A; Lin CC
    Antimicrob Agents Chemother; 1997 Aug; 41(8):1794-6. PubMed ID: 9257763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of intravenously administered isepamicin in men.
    Lin CC; Radwanski E; Korduba C; Cayen M; Affrime M
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2774-8. PubMed ID: 8593018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of isepamicin.
    Barr WH; Colucci R; Radwanski E; Zampaglione N; Cutler D; Lin CC; Elliott M; Affrime MB
    J Chemother; 1995 Jun; 7 Suppl 2():53-61. PubMed ID: 8622111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-dose pharmacokinetics of isepamicin in young and geriatric volunteers.
    Nomeir AA; Radwanski E; Cutler D; Affrime M; Christopher D; Korduba C; Batra V; Lin CC; Cayen MN
    J Clin Pharmacol; 1997 Nov; 37(11):1021-30. PubMed ID: 9505995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of intramuscularly administered isepamicin in man.
    Lin CC; Radwanski E; Korduba C; Affrime M; Cayen MN
    Chemotherapy; 1997; 43(2):86-93. PubMed ID: 9084916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacokinetics and pharmacodynamics of isepamicin.
    Tod M; Padoin C; Petitjean O
    Clin Pharmacokinet; 2000 Mar; 38(3):205-23. PubMed ID: 10749517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Metabolic fate of 14C-isepamicin sulfate (14C-HAPA-B) in rats. I. Absorption, distribution, metabolism and excretion after a single intramuscular and intravenous administration].
    Iwasaki M; Serizawa K; Suzuki T; Morishita M; Takahashi T; Muranishi S
    Jpn J Antibiot; 1987 Jan; 40(1):239-52. PubMed ID: 3586333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on the metabolic fate of isepamicin sulfate (HAPA-B). I. Absorption, distribution, metabolism and excretion in rats].
    Suzuki T; Serizawa K; Somiya Y; Shirai M; Endo S; Morishita M
    Jpn J Antibiot; 1987 Jan; 40(1):188-201. PubMed ID: 3586328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Key pharmacokinetic parameters of isepamicin in febrile neutropenic cancer patients and in women with acute pelvic inflammatory disease.
    Yombi JC; Wallemacq P; Leal T; Gala JL; Vandercam B
    J Chemother; 2005 Oct; 17(5):521-6. PubMed ID: 16323441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of isepamicin during continuous venovenous hemodiafiltration.
    Breilh D; Allaouchiche B; Jaumain H; Boulétreau P; Chassard D; Malbec I; Ducint D; Saux MC
    Antimicrob Agents Chemother; 1999 Oct; 43(10):2409-11. PubMed ID: 10508016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition, metabolism, and excretion of [14C]doripenem after a single 500-milligram intravenous infusion in healthy men.
    Cirillo I; Mannens G; Janssen C; Vermeir M; Cuyckens F; Desai-Krieger D; Vaccaro N; Kao LM; Devineni D; Redman R; Turner K
    Antimicrob Agents Chemother; 2008 Oct; 52(10):3478-83. PubMed ID: 18644951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusion of isepamicin into cancellous and cortical bone tissue.
    Boselli E; Breilh D; Bel JC; Debon R; Saux MC; Chassard D; Allaouchiche B
    J Chemother; 2002 Aug; 14(4):361-5. PubMed ID: 12420853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on the metabolic fate of isepamicin sulfate (HAPA-B). III. Intramuscular, intravenous and drip intravenous administration of HAPA-B in rabbits].
    Suzuki T; Somiya Y; Shirai M; Sakai A; Iwasaki M; Morishita M
    Jpn J Antibiot; 1987 Jan; 40(1):208-19. PubMed ID: 3586330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on the metabolic fate of isepamicin sulfate (HAPA-B). IV. Intramuscular, intravenous and drip intravenous administration of HAPA-B in dogs].
    Serizawa K; Shirai M; Endo S; Suzuki T; Morishita M
    Jpn J Antibiot; 1987 Jan; 40(1):220-31. PubMed ID: 3586331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute intravenous and inhalation pharmacokinetics of 2,4-pentanedione in the Fischer 344 rat.
    Frantz SW; Ballantyne B; Leung HW
    Toxicol Ind Health; 1998; 14(3):413-28. PubMed ID: 9569447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of ethylene glycol. III. Plasma disposition and metabolic fate after single increasing intravenous, peroral, or percutaneous doses in the male Sprague-Dawley rat.
    Frantz SW; Beskitt JL; Tallant MJ; Zourelias LA; Ballantyne B
    Xenobiotica; 1996 May; 26(5):515-39. PubMed ID: 8736063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
    Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
    Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of isepamicin in paediatric patients.
    Scaglione F; Viganò A; Colucci R; Zampaglione N; Lin CC; Cutler D; Guerciolini R; Elliott M; Affrime M; Radwanski E
    J Chemother; 1995 Jun; 7 Suppl 2():63-9. PubMed ID: 8622112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism, excretion, and pharmacokinetics of [14C]tigecycline, a first-in-class glycylcycline antibiotic, after intravenous infusion to healthy male subjects.
    Hoffmann M; DeMaio W; Jordan RA; Talaat R; Harper D; Speth J; Scatina J
    Drug Metab Dispos; 2007 Sep; 35(9):1543-53. PubMed ID: 17537869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.